Intelomed

Operating

Intelomed, Inc.

Healthcare · Technology · Founded 2005

Visit website

Real-time remote health metrics

Post-money valuation ⓘ

$28.2M

As of Jan 2023 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price

Total raised

$11,420,347

Crowd $0 · Private $11.4M · 8 rounds since 2010

Latest share price

$1.20

Reg CF · Preferred Stock · Oct 2022 offering price

Financials

FY2020–FY2021 · from SEC filings · hover any figure for its source

$14K

−$1.3M

2020

$33K

−$1.3M

2021

RevenueNet income — beside revenue when positive, below the line when a loss

Metric

FY2020 reviewed

FY2021 reviewed

Income statement

Revenue

$14,150

$33,203

Cost of goods sold

$70

$3,752

Gross margin

100%

89%

Net income

-$1,265,112

-$1,266,445

Taxes paid

Balance sheet

Cash

$738,197

$267,374

Accounts receivable

$3,440

$14,760

Total assets

$991,820

$513,556

Short-term debt

$102,511

$108,150

Long-term debt

$4,552,082

$5,334,624

Total liabilities

$4,654,593

$5,442,774

Other

Headcount

—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in

$28.1M

pre-money

Reg CF · Preferred · Oct 2022

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Reg CF · Preferred Stock · Oct 2022Withdrawnvia StartEngine

Raised $90.4K / $1.1MPost-money $28.2M

Rule 506(b) · Debt · Dec 2016Closed

Raised $502.4KInvestors 10

Rule 506(b) · Equity · Jan 2016Closed

Raised $1.9MInvestors 8

Rule 506(b) · Equity · Jul 2014Closed

Raised $3.8MInvestors 29

Reg D · Equity · Sep 2013Closed

Raised $2.4MInvestors 22

Reg D · Equity · Dec 2012Closed

Raised —

Reg D · Equity · May 2011Closed

Raised $2.6MInvestors 15

Reg D · Equity · Jan 2010Closed

Raised $200KInvestors 1

Team

3 people

William P. Malloy

CEO, Director, Principal Accounting Officer

Mark Rossi

Chairman of the Board

Ned Laubacher

Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

29 investors

holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

View all 10 filings on EDGAR

Form C-WFeb 7, 20230001665160-23-000195
EDGAR
Form COct 11, 20220001665160-22-002745
EDGAR
Form DJan 9, 20170001213900-17-000177
EDGAR
Form D/AJan 29, 20160001482781-16-000003
EDGAR
Form DJan 27, 20160001482781-16-000002
EDGAR
Form DJul 23, 20140001482781-14-000002
EDGAR
Form DSep 10, 20130001482781-13-000001
EDGAR
Form DDec 5, 20120001482781-12-000001
EDGAR

Source: ManualCIK 0001482781Share price $1.20

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.